The price of tenofovir-emtricitabine undermines the cost-effectiveness and advancement of pre-exposure prophylaxis.

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
Add to Saved list
  • Author(s): Keller SB; Smith DM
  • Source:
    AIDS (London, England) [AIDS] 2011 Nov 28; Vol. 25 (18), pp. 2308-10.
  • Publication Type:
    Letter; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
  • Language:
    English
  • Additional Information
    • Source:
      Publisher: Lippincott Williams & Wilkins Country of Publication: England NLM ID: 8710219 Publication Model: Print Cited Medium: Internet ISSN: 1473-5571 (Electronic) Linking ISSN: 02699370 NLM ISO Abbreviation: AIDS Subsets: MEDLINE
    • Publication Information:
      Publication: 1998- : London, England : Lippincott Williams & Wilkins
      Original Publication: London : Gower Academic Journals, c1987-
    • Subject Terms:
      Adenine/*analogs & derivatives ; Antiviral Agents/*economics ; Deoxycytidine/*analogs & derivatives ; Drug Costs/*statistics & numerical data ; HIV Infections/*economics ; Organophosphonates/*economics; Adenine/administration & dosage ; Adenine/economics ; Anti-HIV Agents/administration & dosage ; Anti-HIV Agents/economics ; Antiviral Agents/administration & dosage ; Cost-Benefit Analysis ; Deoxycytidine/administration & dosage ; Deoxycytidine/economics ; Drug Therapy, Combination/economics ; Emtricitabine ; HIV Infections/prevention & control ; Humans ; Models, Economic ; Organophosphonates/administration & dosage ; Tenofovir
    • References:
      N Engl J Med. 2010 Dec 30;363(27):2587-99. (PMID: 21091279)
      Ann Intern Med. 2010 Dec 21;153(12):778-89. (PMID: 21173412)
      N Engl J Med. 2001 Mar 15;344(11):824-31. (PMID: 11248160)
      MMWR Morb Mortal Wkly Rep. 2011 Jan 28;60(3):65-8. (PMID: 21270743)
      Top HIV Med. 2009 Sep-Oct;17(4):130-4. (PMID: 19890185)
      N Engl J Med. 2011 Apr 7;364(14):1372-3; author reply 1374-5. (PMID: 21470026)
      Clin Infect Dis. 2009 Mar 15;48(6):806-15. (PMID: 19193111)
      Med Care. 2008 Apr;46(4):343-5. (PMID: 18362811)
      Am J Epidemiol. 2011 Jul 15;174(2):203-10. (PMID: 21586631)
    • Grant Information:
      R21 AI077304 United States AI NIAID NIH HHS; AI043638 United States AI NIAID NIH HHS; R01 AI047745 United States AI NIAID NIH HHS; UM1 AI069432 United States AI NIAID NIH HHS; AI36214 United States AI NIAID NIH HHS; MH083552 United States MH NIMH NIH HHS; R21 AI047745 United States AI NIAID NIH HHS; U01 AI043638 United States AI NIAID NIH HHS; R56 AI047745 United States AI NIAID NIH HHS; MH62512 United States MH NIMH NIH HHS; P30 AI036214 United States AI NIAID NIH HHS; R01 MH083552 United States MH NIMH NIH HHS; AI077304 United States AI NIAID NIH HHS; AI080353 United States AI NIAID NIH HHS; AI047745 United States AI NIAID NIH HHS; U01 AI069432 United States AI NIAID NIH HHS; AI74621 United States AI NIAID NIH HHS; P30 MH062512 United States MH NIMH NIH HHS; R21 AI080353 United States AI NIAID NIH HHS; AI69432 United States AI NIAID NIH HHS; P01 AI074621 United States AI NIAID NIH HHS
    • Accession Number:
      0 (Anti-HIV Agents)
      0 (Antiviral Agents)
      0 (Organophosphonates)
      0W860991D6 (Deoxycytidine)
      99YXE507IL (Tenofovir)
      G70B4ETF4S (Emtricitabine)
      JAC85A2161 (Adenine)
    • Publication Date:
      Date Created: 20111110 Date Completed: 20120131 Latest Revision: 20211021
    • Publication Date:
      20221216
    • Accession Number:
      PMC3874210
    • Accession Number:
      10.1097/QAD.0b013e32834d3cab
    • Accession Number:
      22067201